Brookfield Corp’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-36,637
Closed -$3.44M 255
2023
Q2
$3.44M Buy
36,637
+28,798
+367% +$2.25M 0.01% 339
2023
Q1
$532K Sell
7,839
-21,014
-73% -$1.35M ﹤0.01% 574
2022
Q4
$1.43M Buy
+28,853
New +$1.18M 0.01% 458
2021
Q1
Sell
-2,302
Closed -$305K 491
2020
Q4
$305K Sell
2,302
-11,576
-83% -$1.4M ﹤0.01% 420
2020
Q3
$1.42M Buy
+13,878
New +$1.2M 0.01% 280

Other funds holding EXAS

Brookfield Corp's EXAS Position: Q3 2023 in Review

Brookfield Corp sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 36,637 shares — an estimated $3.44M sold.

Brookfield Corp first reported a position in EXAS in Q3 2020 and held it in 5 quarters. The position peaked at $3.44M in Q2 2023. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Brookfield Corp reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 36,637 Exact Sciences shares in Q3 2023, an estimated $3.44M.
  • Brookfield Corp first reported a position in Exact Sciences in Q3 2020 and held it in 5 quarters.
  • Brookfield Corp's Exact Sciences position peaked at $3.44M in Q2 2023.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.